Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer

被引:49
作者
Drieskens, O
Stroobants, S
Gysen, M
Vandenbosch, G
Mortelmans, L
Vergote, I [1 ]
机构
[1] Univ Hosp Leuven, Dept Gynecol Oncol, BE-3000 Louvain, Belgium
[2] Univ Hosp Leuven, Dept Radiol, BE-3000 Louvain, Belgium
[3] Univ Hosp Leuven, Dept Nucl Med, BE-3000 Louvain, Belgium
关键词
positron emission tomography; fluoro-2-deoxy-D-glucose; peritoneal metastases; ovarian cancer; CLINICAL-VALUE; PET; CARCINOMA;
D O I
10.1159/000071525
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aim of this prospective study was to evaluate F-18-FDG-PET, in comparison with CT, for the detection of peritoneal and retroperitoneal metastases of ovarian cancer. Methodology. 13 patients with primary (n = 7) or recurrent (n = 6) ovarian cancer underwent an attenuation-corrected F-18-FDG-PET of the abdomen as well as a contrast-enhanced abdominal CT, followed by surgical staging. For data analysis, the abdomen was artificially divided into six regions (right and left subphrenic region, right and left paracolic gutter, retroperitoneum and central abdomen). All images were reviewed and each region was visually scored on F-18-FDG-PET as well as on CT. F-18-FDG-PET results were compared with those of CT, using the surgical data as gold standard. Results: 73 regions were evaluable surgically and or histologically. Sensitivity was slightly better for CT than for F-18-FDG-PET (74 vs. 66%). Metastases of <5 mm were missed with both techniques. Specificity, however, was clearly better for F-18-FDG-PET than for CT (94 vs. 77%), especially in patients with recurrent disease, where postoperative changes (hematomas, adhesions, etc.) caused more false positive results on CT. Retroperitoneal lymph node involvement was found in 3/13 patients. The result of F-18-FDG-PET for the retroperitoneal lymph nodes was correct in all cases, whereas CT was false positive in 2 patients. F-18-FDG-PET is relatively inaccurate for the right and the left subphrenic region (missing tumor involvement in 5 patients compared to 2 patients for CT). Conclusion: Given the low sensitivity of both F-18-FDG-PET and CT for the detection of peritoneal metastases, surgical staging remains the gold standard. Because of the better specificity, F-18-FDG-PET might be preferred for evaluating residual or recurrent disease after surgery. F-18-FDG-PET was more sensitive in the retroperitoneal region than intraperitoneal. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:130 / 134
页数:5
相关论文
共 19 条
[1]   Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology Part II.: The clinical value in detecting and staging primary tumours [J].
Ak, I ;
Stokkel, MPM ;
Pauwels, EKJ .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (10) :560-574
[2]   CANCER STATISTICS, 1994 [J].
BORING, CC ;
SQUIRES, TS ;
TONG, T ;
MONTGOMERY, S .
CA-A CANCER JOURNAL FOR CLINICIANS, 1994, 44 (01) :7-26
[3]  
Bristow RE, 1996, CANCER, V78, P2049, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2049::AID-CNCR4>3.0.CO
[4]  
2-J
[5]   Visualisation of bladder cancer using 11C-choline PET:: first clinical experience [J].
de Jong, IJ ;
Pruim, J ;
Elsinga, PH ;
Jongen, MMGJ ;
Mensink, HAJ ;
Vaalburg, W .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (10) :1283-1288
[6]  
DEBELKE D, 1997, J NUCL MED, V38, P1196
[7]  
EINHORN N, 1985, CANCER, V55, P2015
[8]   Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma [J].
Flamen, P ;
Lerut, A ;
Van Cutsem, E ;
De Wever, W ;
Peeters, M ;
Stroobants, S ;
Dupont, P ;
Bormans, G ;
Hiele, M ;
De Leyn, P ;
Van Raemdonck, D ;
Coosemans, W ;
Ectors, N ;
Haustermans, K ;
Mortelmans, L .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) :3202-3210
[9]   Lymph node staging by positron emission tomography in patients with carcinoma of the cervix [J].
Grigsby, PW ;
Siegel, BA ;
Dehdashti, F .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) :3745-3749
[10]   ASSESSMENT OF PRIMARY AND METASTATIC OVARIAN-CANCER BY POSITRON EMISSION TOMOGRAPHY (PET) USING 2-[F-18]DEOXYGLUCOSE (2-[F-18]FDG) [J].
HUBNER, KF ;
MCDONALD, TW ;
NIETHAMMER, JG ;
SMITH, GT ;
GOULD, HR ;
BUONOCORE, E .
GYNECOLOGIC ONCOLOGY, 1993, 51 (02) :197-204